TFX
Teleflex Incorporated
NYSE: TFX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$133.30
-1.64% today
Updated 2026-04-29
Market cap
$5.90B
P/E ratio
101.76
P/S ratio
2.96x
EPS (TTM)
$1.31
Dividend yield
1.00%
52W range
$100 – $140
Volume
0.9M
Teleflex Incorporated (TFX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-45.50%
Operating margin
40.60%
ROE
1.58%
ROA
2.59%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.65B | $139.43M | 29.25% | 9.62% | 5.27% |
| 2007 | $1.93B | $146.48M | 35.17% | 9.96% | 7.57% |
| 2008 | $2.42B | $119.77M | 39.83% | 14.04% | 4.95% |
| 2009 | $1.89B | $302.99M | 43.07% | 14.27% | 16.03% |
| 2010 | $1.80B | $201.09M | 44.07% | 15.19% | 11.16% |
| 2011 | $1.53B | $323.33M | 47.02% | 15.25% | 21.15% |
| 2012 | $1.55B | $-190.06M | 48.24% | -6.28% | -12.25% |
| 2013 | $1.70B | $150.88M | 49.46% | 13.75% | 8.89% |
| 2014 | $1.84B | $187.68M | 51.22% | 15.48% | 10.20% |
| 2015 | $1.81B | $244.86M | 52.19% | 17.46% | 13.53% |
| 2016 | $1.87B | $237.38M | 53.33% | 17.10% | 12.71% |
| 2017 | $2.15B | $152.53M | 54.60% | 17.35% | 7.11% |
| 2018 | $2.45B | $200.80M | 56.55% | 13.14% | 8.20% |
| 2019 | $2.60B | $461.47M | 54.29% | 16.46% | 17.78% |
| 2020 | $2.54B | $335.32M | 52.22% | 16.67% | 13.22% |
| 2021 | $2.81B | $485.37M | 55.15% | 22.36% | 17.28% |
| 2022 | $2.79B | $363.14M | 54.86% | 17.90% | 13.01% |
| 2023 | $2.97B | $356.33M | 55.37% | 17.02% | 11.98% |
| 2024 | $3.05B | $69.67M | 55.87% | 4.96% | 2.29% |
| 2025 | $1.99B | $-905.64M | 56.24% | 12.84% | -45.45% |